Epilepsia Open

Papers
(The H4-Index of Epilepsia Open is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Total posterior quadrant disconnection for drug‐resistant epilepsy in children89
Biodegradable nanoparticles for the treatment of epilepsy: From current advances to future challenges64
Comparative efficacy and safety of stiripentol, cannabidiol and fenfluramine as first‐line add‐on therapies for seizures in Dravet syndrome: A network meta‐analysis54
Epilepsy following neonatal encephalopathy—Future directions51
Risk of COVID‐19 infection and seizure exacerbation among patients with epilepsy during the peak of Omicron wave47
Alterations of apparent diffusion coefficient from ultra high b‐values in the bilateral thalamus and striatum in MRI‐negative drug‐resistant epilepsy41
Long‐term effectiveness and tolerability of ketogenic diet therapy in patients with genetic developmental and epileptic encephalopathy onset within the first 6 months of life38
Evaluation of the International League Against Epilepsy 1981, 1989, and 2017 classifications of seizure semiology and etiology in a population‐based cohort of children and adults with epilepsy34
Commentary on “The epileptogenic zone in children with tuberous sclerosis complex is characterized by prominent features of focal cortical dysplasia”32
Patient complexity, depression, and quality of life in patients with epilepsy at an epilepsy center in Japan26
Microglia and status epilepticus in the immature brain26
An interview with Ifrah Zawar, 2023 Epilepsia Open prize winner for clinical research26
Building a dashboard to inform policy and clinical practice using the Irish epilepsy electronic patient record: Towards a learning health system25
Characterization of low‐grade epilepsy‐associated tumor from implanted stereoelectroencephalography electrodes24
Clinical characteristics and outcomes after new‐onset seizure among Zambian children with HIV during the antiretroviral therapy era21
Assessment of tau phosphorylation and β‐amyloid pathology in human drug‐resistant epilepsy21
One‐year seizure freedom and quality of life in patients with drug‐resistant epilepsy receiving adjunctive vagus nerve stimulation in Japan20
Key steps and barriers in the journey of patients with epilepsy through the National Healthcare System in Spain: The EPIPASS qualitative study20
Astrocyte reactivity in a mouse model of SCN8A epileptic encephalopathy20
Intestinal microbiome alterations in pediatric epilepsy: Implications for seizures and therapeutic approaches19
Effectiveness of perampanel as the only add‐on: Retrospective, multicenter, observational real‐life study on epilepsy patients19
0.48408508300781